New Retina Radio
New Retina Radio

09.10.26

Spotlight on UNITY® VCS: Breaking New Ground

In this episode of RetinaLive focused on UNITY® VCS|CS, Jay Sridhar, MD is joined by Nina Berrocal, MD for a forward-looking discussion on adopting next-generation surgical technology. The conversation explores how UNITY® VCS is enabling innovation in a new retina practice setting, with a focus on fluidics stability, integrated anterior and posterior segment capabilities, and enhanced intraoperative efficiency. Through real-world perspectives, the episode highlights the role of advanced technology in simplifying surgical workflows, and supporting the training of the next generation of retina surgeons.

For Important Product Information, visit unityvcs.com.
Speakers are paid Alcon consultants. The views expressed are their own.

Disclaimers:
4:05: Based on Bench Data. UNITY® VCS with HYPERVIT® 30k cpm vitrectomy probe vs. CONSTELLATION® VS with HYPERVIT® 20k cpm vitrectomy probe
6:13: *Mean fluctuation at flow vs. setpoint of 2.36 ± 2.13, 4.19 ± 1.97, 1.84 ± 2.82, and 2.13 ± 2.86 mmHg during phacoemulsification, irrigation/aspiration (IA), vitrectomy, and extrusion/fragmentation, respectively. IOP setpoint as low as 16 mmHg (posterior) and 20 mmHg (anterior) without exceeding a mean fluctuation of 4.19 ± 1.97 mmHg
9:08: MSLP(4) is 3 times faster than SSLP

References:
1. UNITY™ VCS and CS User Manual Unity Phaco Handpiece Directions for Use. 
2. Alcon data on file 2024 (REF-24615)
3. Alcon data on file 2024 (REF-24379)
4. Alcon data on file 2024 (REF-24576)
5. Alcon Data on File (REF-27800)
6. UNITY™ VCS and CS User Manual
7. Alcon data on file 2024. (REF-24899)

Sponsored by Alcon, Inc. © 2026 Alcon Inc. 07/26 US-UVC-2600112

View full description +

MORE EPISODES

09.10.26

Spotlight on UNITY® VCS: Breaking New Ground

Jay Sridhar, MD; and Nina Berrocal, MD

08.27.26

ASRS '26: ArMaDa/GARDian Results and Real-World YAG Complication Incidence

Jay Chhablani, MD; and Jordan Deaner, MD

08.20.26

Comparing Ocular AEs in Next-Gen Treatments

Katherine Talcott, MD; Akshay Thomas, MD; and Nita Valikodath, MD, MS

08.18.26

The Story Behind LYTENAVA™: From FDA Approval to Retina Practice

Barry Kuppermann, MD, PhD; and Bob Jahr, CEO of Outlook Therapeutics

08.12.26

The Fellow Eye: Episode 6

Justin C. Muste, MD; David Fell, MD; Monia Reding, MD; and Benjamin Young, MD

08.05.26

ASRS '26: SOL-1 and TRUCKEE at 4.5 Years

Dilsher Dhoot, MD; and Carl Danzig, MD

07.16.26

New Retina Radio Journal Club w/ VBS: Clinical Features and Outcomes of IOFB Removal

Jordan Deaner, MD; Vaidehi Dedania, MD; and Rehan Hussain, MD

07.08.26

Barriers to Care, Patient Education, and Treatment Decisions in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Show More